COVID-19: BioNTech CEO says it’s possible to quickly adapt Pfizer vaccine for Omicron

BioNTech CEO Ugur Sahin said Friday that while there were concerns the Pfizer-BioNTech vaccine may not be as effective against the new Omicron COVID-19 variant, it was possible to quickly adapt the current shot to combat the variant.